KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Capital Leases (2016 - 2018)

Tenet Healthcare's Capital Leases history spans 9 years, with the latest figure at $425.0 million for Q4 2018.

  • For Q4 2018, Capital Leases fell 1.39% year-over-year to $425.0 million; the TTM value through Dec 2018 reached $425.0 million, down 1.39%, while the annual FY2018 figure was $425.0 million, 1.39% down from the prior year.
  • Capital Leases for Q4 2018 was $425.0 million at Tenet Healthcare, roughly flat from $424.0 million in the prior quarter.
  • Across five years, Capital Leases topped out at $853.0 million in Q1 2016 and bottomed at $377.0 million in Q3 2017.
  • The 5-year median for Capital Leases is $485.5 million (2014), against an average of $587.8 million.
  • The largest annual shift saw Capital Leases surged 212.14% in 2014 before it crashed 53.91% in 2017.
  • A 5-year view of Capital Leases shows it stood at $487.0 million in 2014, then surged by 74.95% to $852.0 million in 2015, then dropped by 13.73% to $735.0 million in 2016, then plummeted by 41.36% to $431.0 million in 2017, then dropped by 1.39% to $425.0 million in 2018.
  • Per Business Quant, the three most recent readings for THC's Capital Leases are $425.0 million (Q4 2018), $424.0 million (Q3 2018), and $417.0 million (Q2 2018).